Page last updated: 2024-08-24

gemcitabine and mastoparan

gemcitabine has been researched along with mastoparan in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bally, MB; Corcoran, JA; Franco, OL; Hancock, REW; Haney, EF; Hilchie, AL; Hoskin, DW; Sharon, AJ	1

Other Studies

1 other study(ies) available for gemcitabine and mastoparan

Article	Year
Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma. Biochimica et biophysica acta, 2016, Volume: 1858, Issue:12 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Circular Dichroism; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Humans; Intercellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Peptides; Wasp Venoms	2016

Article

Year

Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma.

Biochimica et biophysica acta, 2016, Volume: 1858, Issue:12

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Circular Dichroism; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Humans; Intercellular Signaling Peptides and Proteins; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Peptides; Wasp Venoms

2016